Xeriant, Inc.: Form 10-Q/A for the period ended Sep 30, 2021
Filed with the SEC on Nov 24, 2021 and accepted by EDGAR at Nov 24, 2021, 16:28 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2021-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Research and development | 3 months2021-07-01 to 2021-09-30 | $2.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2021-07-01 to 2021-09-30 | −$4.3m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months2021-07-01 to 2021-09-30 | $2.4k | us-gaap:InterestExpense |
| Net income | 3 months2021-07-01 to 2021-09-30 | −$4.4m | us-gaap:NetIncomeLoss |
| Operating cash flow | 3 months2021-07-01 to 2021-09-30 | −$2.7m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Cash and equivalents | At period end2021-09-30 | $281.8k | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2021-09-30 | $330.5k | us-gaap:AssetsCurrent |
| Total assets | At period end2021-09-30 | $489.9k | us-gaap:Assets |
| Current liabilities | At period end2021-09-30 | $237.5k | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2021-09-30 | $367.2k | us-gaap:Liabilities |
| Shareholders' equity | At period end2021-09-30 | $122.7k | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001477932-21-008783. Last ingested by Listed: Oct 24, 2026, 15:08 ET. Listed shows no prices and gives no investment advice.